NCT02482454
Active, not recruiting
Phase 2
Phase III Study of Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma
ConditionsCholangiocarcinoma
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Cholangiocarcinoma
- Sponsor
- The First People's Hospital of Changzhou
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- Recurrence-free survival
- Status
- Active, not recruiting
- Last Updated
- 8 years ago
Overview
Brief Summary
The purpose of this study is to determine whether combining of radiofrequency ablation (RFA) and cytokine-induced killer cells (CIK) transfusion can prolong survival of patients with cholangiocarcinoma.
Detailed Description
The primary objective is to evaluate whether RFA followed by CIK transfusion can prolong survival of patients with cholangiocarcinoma.
Investigators
peng du
Director of Science and Education Division
The First People's Hospital of Changzhou
Eligibility Criteria
Inclusion Criteria
- •Patients with histologically confirmed cholangiocarcinoma
- •Primary lesions (cholangiocarcinoma) are not resected
- •Serum bilirubin level of 2.0 mg/dl or less.
- •Performance status of 0 or
- •Expected survival of 1 year or more.
- •Informed consent from the patient.
Exclusion Criteria
- •With extrahepatic metastases
- •With other neoplastic disease that is measurable or being treated other than cholangiocarcinoma.
Outcomes
Primary Outcomes
Recurrence-free survival
Time Frame: 1 year
Recurrence-free survival (RFS) was defined as the time from the date of RFA to the date of recurrence or the date of the last follow-up.
Secondary Outcomes
- Adverse events(4 weeks)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 2
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver MetastasesColorectal CancerNCT02419677The First People's Hospital of Changzhou60
Active, not recruiting
Phase 2
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical CancerCervical CancerNCT02490748The First People's Hospital of Changzhou10
Active, not recruiting
Phase 2
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian CarcinomaOvarian CarcinomaNCT02487693The First People's Hospital of Changzhou50
Unknown
Phase 4
Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular CarcinomaHepatocellular CarcinomaLiver CancerNCT00554905Sun Yat-sen University180
Withdrawn
Phase 4
Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver MetastasesMetastatic Liver CancerSecondary Liver CancerLiver NeoplasmNCT00510627Boston Scientific Corporation